Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

771 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily regimen as a first-line treatment in patients with unresectable advanced pancreatic cancer.
Yamaue H, Shimizu A, Hagiwara Y, Sho M, Yanagimoto H, Nakamori S, Ueno H, Ishii H, Kitano M, Sugimori K, Maguchi H, Ohkawa S, Imaoka H, Hashimoto D, Ueda K, Nebiki H, Nagakawa T, Isayama H, Yokota I, Ohashi Y, Shirasaka T. Yamaue H, et al. Among authors: hashimoto d. Cancer Chemother Pharmacol. 2017 Apr;79(4):813-823. doi: 10.1007/s00280-017-3250-8. Epub 2017 Mar 1. Cancer Chemother Pharmacol. 2017. PMID: 28251282 Clinical Trial.
The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers.
Ikuta Y, Takamori H, Sakamoto Y, Hashimoto D, Chikamoto A, Kuroki H, Sakata K, Sakamoto K, Hayashi H, Imai K, Nitta H, Hirota M, Kanemitsu K, Beppu T, Baba H. Ikuta Y, et al. Among authors: hashimoto d. Int J Clin Oncol. 2014 Aug;19(4):629-33. doi: 10.1007/s10147-013-0613-y. Epub 2013 Sep 3. Int J Clin Oncol. 2014. PMID: 23999903
Efficacy of Staging Laparoscopy for Pancreatic Cancer.
Yamamura K, Yamashita YI, Yamao T, Kuroda D, Eto T, Kitano Y, Arima K, Miyata T, Okabe H, Nitta H, Hashimoto D, Baba H. Yamamura K, et al. Among authors: hashimoto d. Anticancer Res. 2020 Feb;40(2):1023-1027. doi: 10.21873/anticanres.14037. Anticancer Res. 2020. PMID: 32014948
Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal Malignancy Study Group.
Satoi S, Takahara N, Fujii T, Isayama H, Yamada S, Tsuji Y, Miyato H, Yamaguchi H, Yamamoto T, Hashimoto D, Yamaki S, Nakai Y, Saito K, Baba H, Watanabe T, Ishii S, Hayashi M, Kurimoto K, Shimada H, Kitayama J. Satoi S, et al. Among authors: hashimoto d. J Hepatobiliary Pancreat Sci. 2022 Jun;29(6):600-608. doi: 10.1002/jhbp.1085. Epub 2022 Jan 7. J Hepatobiliary Pancreat Sci. 2022. PMID: 34855287 Free PMC article.
Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study).
Yamamoto T, Fujii T, Hirano S, Motoi F, Honda G, Uemura K, Kitayama J, Unno M, Kodera Y, Yamaue H, Shimokawa T, Hashimoto D, Yamaki S, Yoshitomi H, Miura F, Ueno H, Sekimoto M, Satoi S; Study Group of Pancreatic Ductal Adenocarcinoma with Peritoneal Metastasis. Yamamoto T, et al. Among authors: hashimoto d. Trials. 2022 Feb 5;23(1):119. doi: 10.1186/s13063-022-06049-7. Trials. 2022. PMID: 35123553 Free PMC article. Clinical Trial.
Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study.
Hashimoto D, Satoi S, Ishikawa H, Kodera Y, Kamei K, Hirano S, Fujii T, Uemura K, Tsuchida A, Yamada S, Yamamoto T, Hirota K, Sekimoto M. Hashimoto D, et al. Trials. 2022 Feb 12;23(1):135. doi: 10.1186/s13063-021-05934-x. Trials. 2022. PMID: 35151367 Free PMC article.
Factors Affecting Nonfunctioning Small Pancreatic Neuroendocrine Neoplasms and Proposed New Treatment Strategies.
Hijioka S, Yamashige D, Esaki M, Honda G, Higuchi R, Masui T, Shimizu Y, Ohtsuka M, Kumamoto Y, Katanuma A, Gotohda N, Akita H, Unno M, Endo I, Yokoyama Y, Yamada S, Matsumoto I, Ohtsuka T, Hirano S, Yasuda H, Kawai M, Aoki T, Nakamura M, Hashimoto D, Rikiyama T, Horiguchi A, Fujii T, Mizuno S, Hanada K, Tani M, Hatori T, Ito T, Okuno M, Kagawa S, Tajima H, Ishii T, Sugimoto M, Onoe S, Takami H, Takada R, Miura T, Kurita Y, Kamei K, Mataki Y, Okazaki K, Takeyama Y, Yamaue H, Satoi S; Japan Pancreas Society Clinical Research Promotion Committee Group (Corporate Authorship). Hijioka S, et al. Among authors: hashimoto d. Clin Gastroenterol Hepatol. 2024 Jul;22(7):1416-1426.e5. doi: 10.1016/j.cgh.2024.03.029. Epub 2024 Apr 13. Clin Gastroenterol Hepatol. 2024. PMID: 38615727 Free article.
771 results